Percardia CEO Briefs Named Award Recipient at Ernst & Young 2003 New England Entrepreneur Of The Year® Awards Banquet
Merrimack, NH, July 1, 2003 - Nancy M. Briefs, CEO of Percardia Inc., is a recipient of the Ernst & Young 2003 New England Entrepreneur Of The Year® Award. This awards program, now in its 17th year, recognizes the region's best and brightest entrepreneurs, whose contributions drive today's economy and tomorrow's opportunities. The selection was announced at the Awards Banquet held June 26 hosted by Ernst & Young at the Boston Park Plaza Hotel in Boston, MA.
Chosen among finalists from 55 companies by an independent panel of judges, Briefs joins 14 honorees from New England to compete with winners from all of Ernst & Young's other regions at the National Entrepreneur Of The Year® Conference in Palm Springs, California this November. Her award was given in the "Emerging" company category. Previous New England regional award recipients include Ben Cohen and Jerry Greenfield of Ben & Jerry's, Leon Gorman of L.L. Bean, Richard Egan of EMC, Thomas Stemberg of Staples, and Patricia Gallup of PC Connection.
"Possessing the entrepreneurial spirit means believing that you have the freedom and the power to invent a better future, and the passion to make it happen," says Briefs.
According to the sponsors, "these exceptional individuals have shown determination, courage, savvy and creativity, and have persevered during a challenging time to transform their visions into reality." By recognizing these individuals and their accomplishments, the sponsors hope to encourage and contribute to the activities and environments that foster the entrepreneurial spirit.
Percardia Inc. was founded in 1998. It is a mid-stage, venture-backed medical device company dedicated to development and commercialization of proprietary devices for treatment of coronary artery disease (CAD). The company currently is in Phase I clinical trials in Europe of the VCAB/VSTENT myocardial implant device. It is anticipated that the company's technology will require PMA Class III approval for commercialization in the USA and CE Mark for Europe.
Additional information regarding the company and it's technology can be obtained at the company's website www.percardia.com.
Note to Local Editors: Nancy M. Briefs resides in Nashua, NH, with her daughters, Katie and Alexandra.